These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 37440123)

  • 1. Societal Utilities for Cognitive Impairment in Schizophrenia: Developing a Preference-Based Scoring Algorithm Based on the Schizophrenia Cognition Rating Scale.
    Santi I; Lloyd AJ; Hastedt CE; Versteegh MM
    Adv Ther; 2023 Sep; 40(9):4060-4073. PubMed ID: 37440123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of the Persian version of the Schizophrenia Cognition Rating Scale (SCoRS) in patients with schizophrenia.
    Mazhari S; Ghafaree-Nejad AR; Soleymani-Zade S; Keefe RSE
    Asian J Psychiatr; 2017 Jun; 27():12-15. PubMed ID: 28558882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comprehensive review of the research employing the schizophrenia cognition rating scale (SCoRS).
    Harvey PD; Khan A; Atkins A; Walker TM; Keefe RSE
    Schizophr Res; 2019 Aug; 210():30-38. PubMed ID: 31196736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A hybrid modelling approach for eliciting health state preferences: the Portuguese EQ-5D-5L value set.
    Ferreira PL; Antunes P; Ferreira LN; Pereira LN; Ramos-Goñi JM
    Qual Life Res; 2019 Dec; 28(12):3163-3175. PubMed ID: 31201730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of generic and condition-specific measures of health-related quality of life in NICE decision-making: a systematic review, statistical modelling and survey.
    Longworth L; Yang Y; Young T; Mulhern B; Hernández Alava M; Mukuria C; Rowen D; Tosh J; Tsuchiya A; Evans P; Devianee Keetharuth A; Brazier J
    Health Technol Assess; 2014 Feb; 18(9):1-224. PubMed ID: 24524660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Time and lexicographic preferences in the valuation of EQ-5D-Y with time trade-off methodology.
    Lipman SA; Zhang L; Shah KK; Attema AE
    Eur J Health Econ; 2023 Mar; 24(2):293-305. PubMed ID: 35596831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of FACT- and EQ-5D-based utility scores in cancer.
    Pickard AS; Ray S; Ganguli A; Cella D
    Value Health; 2012; 15(2):305-11. PubMed ID: 22433762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychometric evaluation of the patient-reported experience of cognitive impairment in schizophrenia (PRECIS) scale.
    Lenderking WR; Atkinson MJ; Ladd MK; Savva Y; Sommer S; Sidovar M; Hastedt C
    J Patient Rep Outcomes; 2024 Jun; 8(1):61. PubMed ID: 38884842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Schizophrenia Cognition Rating Scale: an interview-based assessment and its relationship to cognition, real-world functioning, and functional capacity.
    Keefe RS; Poe M; Walker TM; Kang JW; Harvey PD
    Am J Psychiatry; 2006 Mar; 163(3):426-32. PubMed ID: 16513863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the performance of algorithms mapping EORTC QLQ-C30 onto the EQ-5D index in a metastatic colorectal cancer cost-effectiveness model.
    Franken MD; de Hond A; Degeling K; Punt CJA; Koopman M; Uyl-de Groot CA; Versteegh MM; van Oijen MGH
    Health Qual Life Outcomes; 2020 Jul; 18(1):240. PubMed ID: 32690011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experience-Based Swedish TTO and VAS Value Sets for EQ-5D-5L Health States.
    Burström K; Teni FS; Gerdtham UG; Leidl R; Helgesson G; Rolfson O; Henriksson M
    Pharmacoeconomics; 2020 Aug; 38(8):839-856. PubMed ID: 32307663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Valuing the EQ Health and Wellbeing Short Using Time Trade-Off and a Discrete Choice Experiment: A Feasibility Study.
    Mukuria C; Peasgood T; McDool E; Norman R; Rowen D; Brazier J
    Value Health; 2023 Jul; 26(7):1073-1084. PubMed ID: 36805577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estimating health state utilities in primary hyperoxaluria type 1: a valuation study.
    de Freitas HM; Danese D; Hubig L; Lloyd A; Lombardelli S
    J Med Econ; 2023; 26(1):386-393. PubMed ID: 36852648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Time Trade-off-derived Value Set of the EQ-5D-5L for Canada.
    Xie F; Pullenayegum E; Gaebel K; Bansback N; Bryan S; Ohinmaa A; Poissant L; Johnson JA;
    Med Care; 2016 Jan; 54(1):98-105. PubMed ID: 26492214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estimating EQ-5D and OAB-5D health state utilities for patients with overactive bladder.
    Desroziers K; Aballéa S; Maman K; Nazir J; Odeyemi I; Hakimi Z
    Health Qual Life Outcomes; 2013 Nov; 11():200. PubMed ID: 24246044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a disease-specific version of the EQ-5D-5L for use in patients suffering from psoriasis: lessons learned from a feasibility study in the UK.
    Swinburn P; Lloyd A; Boye KS; Edson-Heredia E; Bowman L; Janssen B
    Value Health; 2013 Dec; 16(8):1156-62. PubMed ID: 24326169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Value Set for the EQ-5D-Y-3L in Hungary.
    Rencz F; Ruzsa G; Bató A; Yang Z; Finch AP; Brodszky V
    Pharmacoeconomics; 2022 Dec; 40(Suppl 2):205-215. PubMed ID: 36123448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interview-based assessment of cognition is a strong predictor of quality of life in patients with schizophrenia and severe negative symptoms.
    Cruz BF; Resende CB; Carvalhaes CF; Cardoso CS; Teixeira AL; Keefe RS; Rocha FL; Salgado JV
    Braz J Psychiatry; 2016; 38(3):216-21. PubMed ID: 27304257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficient Designs for Valuation Studies That Use Time Tradeoff (TTO) Tasks to Map Latent Utilities from Discrete Choice Experiments to the Interval Scale: Selection of Health States for TTO Tasks.
    Che M; Pullenayegum E
    Med Decis Making; 2023 Apr; 43(3):387-396. PubMed ID: 36866604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interview-based assessment of cognition in schizophrenia: applicability of the Schizophrenia Cognition Rating Scale (SCoRS) in different phases of illness and settings of care.
    Vita A; Deste G; Barlati S; De Peri L; Giambra A; Poli R; Keefe RS; Sacchetti E
    Schizophr Res; 2013 May; 146(1-3):217-23. PubMed ID: 23510596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.